Literature DB >> 81300

Fast axoplasmic transport of noradrenaline and dopamine in mammalian peripheral nerve.

N Ben-Jonathan, R E Maxson, S Ochs.   

Abstract

A fast transport of noradrenaline (NA) at a velocity of 392 mm/day was found in cat peroneal nerve using a double-ligation technique and a new sensitive radioenzymatic assay for catecholamines. The velocity of transport of NA is sufficiently close to that of 410 mm/day found for labelled proteins and polypeptides to be considered as moving down within the nerve fibres by the same transport mechanism. In addition, dopamine (DA) was also found to be moved down by anterograde transport at a fast, but not well defined, rate. Disulfiram, a dopamine-beta-hydroxylase inhibiting agent, reduced NA levels and increased DA both in control nerve segments and within the portion of the nerve isolated by ligations where NA-containing densecore vesicles are present. The results are considered to support a dynamic turnover of NA and DA in the dense-core vesicles as they are trasnported in the axons.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81300      PMCID: PMC1282699          DOI: 10.1113/jphysiol.1978.sp012424

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  26 in total

Review 1.  Dopamine and norepinephrine in noradrenergic axons: a study in vivo of their precursor product relationship by mass fragmentography and radiochemistry.

Authors:  E Costa; A R Green; S H Koslow; H F LeFevre; A V Revuelta; C Wang
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

2.  Local synthesis and breakdown of noradrenaline in constricted rat sciatic nerves.

Authors:  W G McLean; P Keen
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

3.  Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryptamine in the rat spinal cord.

Authors:  T Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  N E Andén; C V Atack; T H Svensson
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

5.  Proximo-distal transport of [14C]noradrenaline and protein in sympathetic nerves.

Authors:  B G Livett; L B Geffen; L Austin
Journal:  J Neurochem       Date:  1968-09       Impact factor: 5.372

6.  Is there bidirectional transport of noradrenaline in sympathetic nerves?

Authors:  L B Geffen; C Hunter; R A Rush
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

7.  Retention and redistribution of proteins in mammalian nerve fibres by axoplasmic transport.

Authors:  S Ochs
Journal:  J Physiol       Date:  1975-12       Impact factor: 5.182

8.  Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitter.

Authors:  H Thoenen; W Haefely; K F Gey; A Hürlimann
Journal:  Life Sci       Date:  1965-11       Impact factor: 5.037

9.  Stop-flow: a new technique for measuring axonal transport, and its application to the transport of dopamine-beta-hydroxylase.

Authors:  S Brimijoin
Journal:  J Neurobiol       Date:  1975-07

10.  The re-distribution of cytochrome oxidase, noradrenaline and adenosine triphosphate in adrenergic nerves constricted at two points.

Authors:  P Banks; D Mangnall; D Mayor
Journal:  J Physiol       Date:  1969-02       Impact factor: 5.182

View more
  2 in total

1.  Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons.

Authors:  J R Tonra; R Curtis; V Wong; K D Cliffer; J S Park; A Timmes; T Nguyen; R M Lindsay; A Acheson; P S DiStefano
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

2.  Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve.

Authors:  Maria Schäfers; Christian Geis; Dominik Brors; Tony L Yaksh; Claudia Sommer
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.